Symbol | Exchange | Currency |
---|
Investing.com – U.S. stocks were higher after the close on Thursday, as gains in the Telecoms, Financials and Oil & Gas sectors led shares higher. At the close in NYSE, the Dow...
On the 25th of March, Orbimed Advisors sold 313 thousand Graybug Vision, Inc. (GRAY) shares for $1.9 million at an average price of $6.16 per share. Shares of Graybug Vision, Inc....
1. Cars.com (CARS) Cars.com (NYSE:CARS) broke out of a base on Wednesday. It came down from 14 to 3, and change, formed a nice base, popped, failed to go to the 50-day, backed...
1. Adverum Biotechnologies (ADVM)ADVM made a powerful move on Tuesday, above a double-top and breakaway gap, and jumped 5.27, or 38%, to 19.00, after reaching a multi-week and...
One stock that might be an intriguing choice for investors right now is Adverum Biotechnologies, Inc. (NASDAQ:ADVM) . This is because this security in the Medical - Biomedical and...
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company, which targets unmet medical needs in ocular and rare diseases. The Company develops gene therapy product candidates. Its lead product candidate, ADVM-022, is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. ADVM-022 is being developed for the treatment of patients with wet age-related macular degeneration (wet AMD) who are responsive to anti-VEGF therapy. The Company's second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to deliver a functional copy of the OPN1LW gene to the foveal cones of patients suffering from blue cone monochromacy (BCM) via a single IVT injection.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Neutral | Sell | Strong Sell | Sell | Sell |
Technical Indicators | Buy | Buy | Strong Sell | Sell | Strong Sell |
Summary | Neutral | Neutral | Strong Sell | Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
265.03 | 265.59 | 261.26 | +2.85 | +1.09% | 915.36K | NYSE | |||
8.10 | 8.12 | 7.85 | -0.26 | -3.16% | 3.34M | NYSE | |||
100.81 | 101.85 | 99.80 | -0.02 | -0.02% | 35.92M | NASDAQ | |||
31.64 | 31.65 | 30.71 | -1.11 | -3.39% | 3.91M | NYSE | |||
176.09 | 179.33 | 171.85 | +4.91 | +2.87% | 3.18M | NASDAQ | |||
4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
1.16 | 1.19 | 1.15 | -0.0500 | -4.13% | 1.63M | NYSE | |||
166.08 | 166.41 | 165.13 | +0.78 | +0.47% | 3.79M | NYSE | |||
45.35 | 45.49 | 44.78 | -0.91 | -1.97% | 1.07M | NYSE | |||
3.525 | 3.55 | 3.47 | -0.075 | -2.08% | 7.04M | NYSE | |||
1.07 | 1.09 | 1.05 | -0.0300 | -2.73% | 74.36K | NYSE | |||
49.68 | 50.06 | 49.40 | -0.43 | -0.86% | 5.94M | NYSE | |||
134.78 | 134.81 | 132.25 | +0.77 | +0.57% | 1.27M | NYSE | |||
7.28 | 7.31 | 6.73 | +0.410 | +5.97% | 3.10M | NYSE | |||
39.37 | 40.38 | 38.81 | -1.37 | -3.36% | 2.84M | NYSE |